Key features and details
- Expression system: Escherichia coli
- Purity: > 95% SDS-PAGE
- Active: Yes
- Suitable for: ELISA, WB
Product nameRecombinant HSV2 gD protein
Immunoreactive with sera from HSV2-infected individuals with minimum specificity problems.
Purity> 95 % SDS-PAGE.
Sepharose derived purification.
Expression systemEscherichia coli
Protein lengthProtein fragment
Amino acids266 to 394
Additional sequence informationThe protein contains the HSV-2 gD immunodominant regions.
Our Abpromise guarantee covers the use of ab43046 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Concentration information loading...
Preparation and Storage
Stability and Storage
Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.
Constituents: 0.395% Tris HCl, 0.0292% EDTA, 50% Glycerol
This product is an active protein and may elicit a biological response in vivo, handle with caution.
- Glycoprotein D precursor
- Herpes Simplex Virus Type 2 Glycoprotein D
- Human Herpesvirus 2
RelevanceThere are eight members of the herpes virus family that are known to cause human disease, including not only the herpes simplex viruses (HSV1 and HSV2). HSV1 and HSV2 are family Herpesviridae, subfamily Alpha herpes virinae, genus Simplexvirus. Glycoprotein D(gD) binds specifically to the herpesvirus entry mediator receptor (HVEM), thus providing a strong, fixed attachment to the host cell. These interactions bring the membrane surfaces into mutual proximity and allow for other surface glycoproteins to interact.
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
ab43046 has not yet been referenced specifically in any publications.